CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-28 | Jovan-Embiricos Morana Director | Grant or award | +684,622 | $4.61 | $3.2M | 2,059,884 |
| 2022-07-28 | Jovan-Embiricos Morana Director | Grant or award | +325,379 | $4.61 | $1.5M | 668,072 |
| 2022-07-28 | Jovan-Embiricos Morana Director | Grant or award | +1,626,898 | $4.61 | $7.5M | 2,038,583 |
| 2022-07-28 | Jovan-Embiricos Morana Director | Grant or award | +1,393,874 | $4.61 | $6.4M | 4,193,874 |
| 2022-07-28 | Jovan-Embiricos Morana Director | Grant or award | +867,678 | $4.61 | $4.0M | 867,678 |
| 2022-07-28 | Jovan-Embiricos Morana Director | Grant or award | +3,253,796 | $4.61 | $15.0M | 16,674,766 |
| 2022-07-28 | ElevateBio, LLC Director | Grant or award | +3,253,796 | $4.61 | $15.0M | 16,674,766 |
| 2022-07-28 | GADICKE ANSBERT Director | Grant or award | +3,253,796 | $4.61 | $15.0M | 16,674,766 |
| 2022-07-21 | Atillasoy Ercem See Remarks | Sale | −1,533 | $5.38 | $8K | 133,467 |
| 2022-07-21 | Hallal David Director | Sale | −4,227 | $5.33 | $23K | 2,073,662 |
| 2022-07-20 | Sinha Vikas See Remarks | Sale | −1,432 | $5.21 | $7K | 938,224 |
| 2022-07-20 | Atillasoy Ercem See Remarks | Sale | −563 | $5.21 | $3K | 135,000 |
| 2022-07-20 | VAN BEEK JEROEN B Chief Commercial Officer | Sale | −1,058 | $5.21 | $6K | 401,953 |
| 2022-07-01 | Leen Ann M. Chief Scientific Officer | Grant or award | +14,000 | 65,256 | ||
| 2022-07-01 | Leen Ann M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +26,000 | 392,344 | ||
| 2022-07-01 | Hagen Brett R Chief Accounting Officer | Grant or award | +10,500 | 93,578 | ||
| 2022-07-01 | Hagen Brett R Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +19,500 | 19,500 | ||
| 2022-01-18 | Leen Ann M. Chief Scientific Officer | Grant or award | +23,256 | 51,256 | ||
| 2022-01-18 | Leen Ann M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +56,744 | 366,344 |
Page 13 of 13 · 259 trades